|
KLF7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.965600E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.480800E-03 |
| Normal-vs-Stage2 |
6.830100E-04 |
| Normal-vs-Stage3 |
1.239900E-03 |
| Normal-vs-Stage4 |
1.485660E-02 |
| Stage1-vs-Stage2 |
7.908000E-02 |
| Stage1-vs-Stage3 |
2.328800E-01 |
| Stage1-vs-Stage4 |
6.496800E-01 |
| Stage2-vs-Stage3 |
4.503200E-01 |
| Stage2-vs-Stage4 |
3.081000E-01 |
| Stage3-vs-Stage4 |
6.924600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.618100E-03 |
| Normal-vs-AfricanAmerican |
3.376400E-01 |
| Normal-vs-Asian |
3.857500E-03 |
| Caucasian-vs-AfricanAmerican |
3.328400E-01 |
| Caucasian-vs-Asian |
4.408800E-01 |
| AfricanAmerican-vs-Asian |
1.639830E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.617100E-04 |
| Normal-vs-Female |
2.441500E-03 |
| Male-vs-Female |
1.306190E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.456300E-02 |
| Normal-vs-Age(41-60Yrs) |
1.042680E-03 |
| Normal-vs-Age(61-80Yrs) |
2.22569999999145E-05 |
| Normal-vs-Age(81-100Yrs) |
1.044580E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.676040E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.858700E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.684600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.733600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.641200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.957200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.337400E-01 |
| Classical-VS-Follicular |
2.029900E-02 |
| Classical-VS-Other |
3.804200E-01 |
| Classical-VS-Normal |
5.500700E-03 |
| Tall-VS-Follicular |
5.439200E-01 |
| Tall-VS-Other |
6.950600E-01 |
| Tall-VS-Normal |
2.687700E-02 |
| Follicular-VS-Other |
9.355600E-01 |
| Follicular-VS-Normal |
3.158800E-04 |
| Other-VS-Normal |
9.020200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.188660E-04 |
| Normal-vs-N1 |
2.811900E-02 |
| N0-vs-N1 |
3.308600E-01 |
|
|
